chartexchange

VRAX
Virax Biolabs Group Limited
stockNASDAQ

At CloseNov 18, 2026 3:57:27 PM EST
0.42USD-5.639%(-0.03)376,791
Pre-marketNov 18, 2026 9:28:30 AM EST
0.44USD-1.146%(-0.01)
After-hoursNov 18, 2026 4:45:30 PM EST
0.40USD-4.762%(-0.02)
Loading…
Loading…
551,445
Healthcare
Biotechnology
HQ
London, United Kingdom
Previous Close
$0.45
Beta
2.20
52-Week High
$21.75 2025-12-03
52-Week Low
$0.40 2026-11-16
SMA 50
$1.70
SMA 200
$3.53
Avg. Vol 10D
1.71M
Avg. Vol 30D
602,924
Avg. Vol 90D
629,475
Relative Vol
0.62
19.57M
1454.74%
60.6000%
6,646
Jun 26, 2026 · 1-for-25 (reverse)
VRAX Performance
PeriodPriceDateChangeBeta
1W0.632026-11-11-34.62%16.052
1M1.402026-10-19-70.71%1.174
3M2.762026-08-18-85.14%0.916
6M5.882026-05-18-93.02%0.939
1Y11.272025-11-18-96.36%2.198
2Y47.002024-11-18-99.13%—
5Y4,550.002022-07-21-99.99%0.943
VRAX Stock Summary

Virax Biolabs Group Limited (NASDAQ:VRAX) stock price today is $0.41, and today's volume is 376,791. VRAX is down 7.886% today. The 30 day average volume is 602,924. VRAX market cap is $551,445 with 1.34M shares outstanding.